| BCBS Highmark Penn Medicare Advantage | Self-Administered Drug Exclusion List | 2025-08-31 |
| Medicare CGS | Billing and Coding: Transesophageal Echocardiography (TEE) (56809) | 2025-08-29 |
| Medicare CGS | Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (57038) | 2025-08-29 |
| Medicare CGS | Billing and Coding: Stretta Procedure (57039) | 2025-08-29 |
| Medicare CGS | Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (58359) | 2025-08-29 |
| Medicare Palmetto | Billing and Coding: MolDX: Germline testing for use of PARP inhibitors (54338) | 2025-08-29 |
| Medicare Palmetto | Billing and Coding: Instructions for Lemtrada– (alemtuzumab) When Used in the Treatment of Relapsing Multiple Sclerosis (55310) | 2025-08-28 |
| Molina Clinical Policy | Implanted Tibial Nerve Stimulation for Urinary Incontinence MEDICARE | 2025-08-27 |
| Aetna | Atezolizumab (Tecentriq) and Atezolizumab and Hyaluronidase-tqjs (Tecentriq Hybreza) | 2025-08-27 |
| Aetna | Cemiplimab-rwlc (Libtayo) | 2025-08-27 |